New York State Teachers Retirement System Acquires 200 Shares of Encompass Health Co. (NYSE:EHC)

New York State Teachers Retirement System grew its holdings in shares of Encompass Health Co. (NYSE:EHC) by 0.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 76,102 shares of the company’s stock after buying an additional 200 shares during the quarter. New York State Teachers Retirement System owned 0.08% of Encompass Health worth $7,028,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the business. TD Private Client Wealth LLC grew its stake in Encompass Health by 2,870.0% in the third quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company’s stock worth $709,000 after purchasing an additional 7,089 shares in the last quarter. Los Angeles Capital Management LLC grew its stake in Encompass Health by 532.4% in the third quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock worth $4,860,000 after purchasing an additional 42,338 shares in the last quarter. Pathstone Holdings LLC grew its stake in Encompass Health by 54.5% in the third quarter. Pathstone Holdings LLC now owns 21,022 shares of the company’s stock worth $2,032,000 after purchasing an additional 7,412 shares in the last quarter. Meeder Asset Management Inc. grew its stake in Encompass Health by 43.8% in the third quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company’s stock worth $6,417,000 after purchasing an additional 20,242 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in Encompass Health by 1.2% in the third quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock worth $161,781,000 after purchasing an additional 20,547 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Trading Down 0.5 %

Shares of Encompass Health stock opened at $101.65 on Thursday. Encompass Health Co. has a 52-week low of $73.02 and a 52-week high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The company’s 50-day simple moving average is $95.97 and its 200-day simple moving average is $95.73. The firm has a market cap of $10.24 billion, a price-to-earnings ratio of 22.79, a price-to-earnings-growth ratio of 2.33 and a beta of 0.90.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, equities research analysts anticipate that Encompass Health Co. will post 4.81 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have weighed in on EHC shares. William Blair restated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Truist Financial restated a “buy” rating and set a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. KeyCorp upped their target price on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Monday, February 10th. Royal Bank of Canada restated an “outperform” rating and set a $110.00 target price on shares of Encompass Health in a report on Tuesday, February 11th. Finally, Barclays upped their target price on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. Ten investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $107.67.

Insider Activity

In related news, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 2.10% of the company’s stock.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.